Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova.

Stamoulis joins Mallinckrodt from Incyte, a leading biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. In addition ...

Buildout includes Gerteis Macro-Pactor install to meet growing demand for complex oral solid dose development and manufacturing.

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

Developed by Autolus Therapeutics, AUCATZYL is approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). This follows prior authorizations from ...

The Vibativ 4-Vial Starter Pak is an FDA-approved injectable antibiotic indicated to treat HABP/VABP and complicated skin and ...

Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analytical services, appointed Jarlath Keating as ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.